|
WO2012095743A2
|
|
Adipose -derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases
|
|
GB201012186D0
|
|
Methods for the preparation of cellular therapies
|
|
GB0918615D0
|
|
Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
|
|
GB0912573D0
|
|
Methods for the preparation of the cellular therapies
|
|
GB0904471D0
|
|
Cell population having immunoregulatory activity, methods for the preparation and uses thereof
|
|
GB0820397D0
|
|
Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
|
|
GB0817571D0
|
|
Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
|
|
GB0814249D0
|
|
Uses of mesenchymal stem cells
|
|
GB0809361D0
|
|
Injection device
|
